tiprankstipranks
Cencora (CH:ABG)
:ABG
Switzerland Market

Cencora (ABG) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ABG Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Cencora
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ABG Stock 12 Month Forecast

Average Price Target

CHF303.56
▲(25.13% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is CHF303.56 with a high forecast of CHF349.86 and a low forecast of CHF268.49. The average price target represents a 25.13% change from the last price of CHF242.59.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"241":"CHF241","350":"CHF350","268.25":"CHF268.3","295.5":"CHF295.5","322.75":"CHF322.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":349.8566,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF349.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":303.561622,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF303.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":268.4946,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF268.49</span>\n  </div></div>","useHTML":true}}],"tickPositions":[241,268.25,295.5,322.75,350],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.588,250.83943076923077,259.0908615384615,267.34229230769233,275.5937230769231,283.84515384615383,292.0965846153846,300.3480153846154,308.59944615384615,316.85087692307695,325.1023076923077,333.35373846153846,341.6051692307692,{"y":349.8566,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.588,247.2782786153846,251.96855723076922,256.65883584615386,261.3491144615385,266.0393930769231,270.7296716923077,275.4199503076923,280.11022892307693,284.80050753846155,289.49078615384616,294.1810647692308,298.8713433846154,{"y":303.561622,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.588,244.5808153846154,246.57363076923076,248.56644615384616,250.55926153846153,252.55207692307692,254.5448923076923,256.53770769230766,258.5305230769231,260.52333846153846,262.5161538461538,264.5089692307692,266.5017846153846,{"y":268.4946,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":242.588,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.588,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF349.86Average Price TargetCHF303.56Lowest Price TargetCHF268.49
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI
CHF284.77
Buy
17.39%
Upside
Reiterated
08/13/26
Cencora (COR) Gets a Buy from Evercore ISI
Bank of America Securities Analyst forecast on CH:ABG
Bank of America Securities
Bank of America Securities
CHF252.22CHF268.49
Hold
10.68%
Upside
Reiterated
08/12/26
Bank of America Securities Remains a Hold on Cencora (COR)
Wells Fargo Analyst forecast on CH:ABG
Wells Fargo
Wells Fargo
CHF269.31CHF321.38
Buy
32.48%
Upside
Assigned
08/11/26
Wells Fargo Gives a Buy Rating to Cencora (COR)
J.P. Morgan Analyst forecast on CH:ABG
J.P. Morgan
J.P. Morgan
CHF317.31
Buy
30.80%
Upside
Reiterated
08/10/26
J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)
TD Cowen
CHF325.45
Buy
34.16%
Upside
Reiterated
08/09/26
Cencora: Strong U.S. Health Care Momentum and Solid Long‑Term EPS Outlook Underpin Buy Rating
Morgan Stanley Analyst forecast on CH:ABG
Morgan Stanley
Morgan Stanley
CHF278.26CHF281.51
Buy
16.04%
Upside
Assigned
08/07/26
Cencora (COR) Gets a Buy from Morgan Stanley
Robert W. Baird Analyst forecast on CH:ABG
Robert W. Baird
Robert W. Baird
CHF276.63CHF301.04
Buy
24.09%
Upside
Reiterated
08/06/26
Cencora price target raised to $370 from $340 at BairdCencora price target raised to $370 from $340 at Baird
UBS
CHF335.21CHF349.86
Buy
44.22%
Upside
Reiterated
08/06/26
UBS Reaffirms Their Buy Rating on Cencora (COR)
Citi
CHF288.84CHF301.04
Buy
24.09%
Upside
Reiterated
08/06/26
Cencora price target raised to $370 from $355 at CitiCencora price target raised to $370 from $355 at Citi
William Blair Analyst forecast on CH:ABG
William Blair
William Blair
Hold
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (NYSE: COR), American Well (NYSE: AMWL) and BeOne Medicines (NASDAQ: ONC)
Barclays
CHF284.77
Buy
17.39%
Upside
Reiterated
08/05/26
Barclays Sticks to Their Buy Rating for Cencora (COR)
Argus Research Analyst forecast on CH:ABG
Argus Research
Argus Research
CHF325.45
Buy
34.16%
Upside
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)
Jefferies
CHF268.49CHF357.99
Buy
47.57%
Upside
Upgraded
01/22/26
Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies
Deutsche Bank  Analyst forecast on CH:ABG
Deutsche Bank
Deutsche Bank
CHF261.99CHF301.85
Buy
24.43%
Upside
Reiterated
11/07/25
Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank
Mizuho Securities Analyst forecast on CH:ABG
Mizuho Securities
Mizuho Securities
CHF276.63CHF309.18
Buy
27.45%
Upside
Reiterated
11/06/25
Cencora price target raised to $380 from $340 at MizuhoCencora price target raised to $380 from $340 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI
CHF284.77
Buy
17.39%
Upside
Reiterated
08/13/26
Cencora (COR) Gets a Buy from Evercore ISI
Bank of America Securities Analyst forecast on CH:ABG
Bank of America Securities
Bank of America Securities
CHF252.22CHF268.49
Hold
10.68%
Upside
Reiterated
08/12/26
Bank of America Securities Remains a Hold on Cencora (COR)
Wells Fargo Analyst forecast on CH:ABG
Wells Fargo
Wells Fargo
CHF269.31CHF321.38
Buy
32.48%
Upside
Assigned
08/11/26
Wells Fargo Gives a Buy Rating to Cencora (COR)
J.P. Morgan Analyst forecast on CH:ABG
J.P. Morgan
J.P. Morgan
CHF317.31
Buy
30.80%
Upside
Reiterated
08/10/26
J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)
TD Cowen
CHF325.45
Buy
34.16%
Upside
Reiterated
08/09/26
Cencora: Strong U.S. Health Care Momentum and Solid Long‑Term EPS Outlook Underpin Buy Rating
Morgan Stanley Analyst forecast on CH:ABG
Morgan Stanley
Morgan Stanley
CHF278.26CHF281.51
Buy
16.04%
Upside
Assigned
08/07/26
Cencora (COR) Gets a Buy from Morgan Stanley
Robert W. Baird Analyst forecast on CH:ABG
Robert W. Baird
Robert W. Baird
CHF276.63CHF301.04
Buy
24.09%
Upside
Reiterated
08/06/26
Cencora price target raised to $370 from $340 at BairdCencora price target raised to $370 from $340 at Baird
UBS
CHF335.21CHF349.86
Buy
44.22%
Upside
Reiterated
08/06/26
UBS Reaffirms Their Buy Rating on Cencora (COR)
Citi
CHF288.84CHF301.04
Buy
24.09%
Upside
Reiterated
08/06/26
Cencora price target raised to $370 from $355 at CitiCencora price target raised to $370 from $355 at Citi
William Blair Analyst forecast on CH:ABG
William Blair
William Blair
Hold
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (NYSE: COR), American Well (NYSE: AMWL) and BeOne Medicines (NASDAQ: ONC)
Barclays
CHF284.77
Buy
17.39%
Upside
Reiterated
08/05/26
Barclays Sticks to Their Buy Rating for Cencora (COR)
Argus Research Analyst forecast on CH:ABG
Argus Research
Argus Research
CHF325.45
Buy
34.16%
Upside
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)
Jefferies
CHF268.49CHF357.99
Buy
47.57%
Upside
Upgraded
01/22/26
Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies
Deutsche Bank  Analyst forecast on CH:ABG
Deutsche Bank
Deutsche Bank
CHF261.99CHF301.85
Buy
24.43%
Upside
Reiterated
11/07/25
Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank
Mizuho Securities Analyst forecast on CH:ABG
Mizuho Securities
Mizuho Securities
CHF276.63CHF309.18
Buy
27.45%
Upside
Reiterated
11/06/25
Cencora price target raised to $380 from $340 at MizuhoCencora price target raised to $380 from $340 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cencora

3 Months
Success Rate
27/40 ratings generated profit
68%
Average Return
+5.63%
Copying Charles Rhyee's trades and holding each position for 3 Months would result in 67.50% of your transactions generating a profit, with an average return of +5.63% per trade.
1 Year
David ToungArgus Research
Success Rate
15/17 ratings generated profit
88%
Average Return
+18.92%
Copying David Toung's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +18.92% per trade.
2 Years
Michael ChernyLeerink Partners
Success Rate
23/25 ratings generated profit
92%
Average Return
+33.06%
Copying Michael Cherny's trades and holding each position for 2 Years would result in 92.00% of your transactions generating a profit, with an average return of +33.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABG Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
3
4
4
1
Buy
12
14
12
9
11
Hold
2
6
6
8
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
23
22
21
19
In the current month, ABG has received 12 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. ABG average Analyst price target in the past 3 months is 303.56.
Each month's total comprises the sum of three months' worth of ratings.

ABG Financial Forecast

ABG Earnings Forecast

Next quarter’s earnings estimate for ABG is CHF3.70 with a range of CHF3.64 to CHF3.75. The previous quarter’s EPS was CHF3.63. ABG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.
Next quarter’s earnings estimate for ABG is CHF3.70 with a range of CHF3.64 to CHF3.75. The previous quarter’s EPS was CHF3.63. ABG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.

ABG Sales Forecast

Next quarter’s sales forecast for ABG is CHF71.41B with a range of CHF70.22B to CHF72.89B. The previous quarter’s sales results were CHF68.65B. ABG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.
Next quarter’s sales forecast for ABG is CHF71.41B with a range of CHF70.22B to CHF72.89B. The previous quarter’s sales results were CHF68.65B. ABG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.

ABG Stock Forecast FAQ

What is CH:ABG’s average 12-month price target, according to analysts?
Based on analyst ratings, Cencora’s 12-month average price target is 303.56.
    What is CH:ABG’s upside potential, based on the analysts’ average price target?
    Cencora has 25.13% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Cencora a Buy, Sell or Hold?
          Cencora has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Cencora’s share price target?
            The average share price target for Cencora is 303.56. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF349.86 ,and the lowest forecast is CHF268.49. The average share price target represents 25.13% Increase from the current price of CHF242.59.
              What do analysts say about Cencora?
              Cencora’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Cencora?
                To buy shares of CH:ABG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.